Faculty Information - TAKEDA Shiho

（Last updated : 2025-07-03 17:07:20）

TAKEDA Shiho
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology

Position Assistant Professor

■ Published papers

1.	Original article	Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease. 2025/05/31
2.	Original article	Overexpression of plasmalemmal vesicle-associated protein-1 in patient with cyanotic nephropathy: a case report. 2025/03
3.	Original article	Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. 2025/01
4.	Original article	Urinary casts containing crystals in light chain proximal tubulopathy. 2024/11
5.	Original article	Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. 2024/05
6.	Original article	Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2024/02/05
7.	Original article	Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease 2024/01
8.	Original article	Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. 2023/11/03
9.	Original article	Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. 2023/10
10.	Review article	Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD). 2022/11
11.	Original article	Machine learning for morbid glomerular hypertrophy. 2022/11
12.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. 2022/06
13.	Original article	Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
14.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
15.	Original article	Germline Mutations for Kidney Volume in ADPKD 2021/12/13
16.	Original article	Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
17.	Original article	Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
18.	Original article	Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
19.	Original article	Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
20.	Original article	Sex Differences in Time-Series Changes in Pseudo-R²　Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
21.	Original article	Visceral to subcutaneous fat ratio as an indicator of a ≧30％　eGFR decline in chronic kidney disease 2020/11
22.	Original article	Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2020/08
23.	Original article	Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
24.	Original article	High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
25.	Original article	Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
26.	Original article	Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
27.	Original article	Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
28.	Original article	Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome 2019/08/20
29.	Original article	Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients 2019/04
30.	Original article	PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion 2019/01
31.	Original article	Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis:A case report. 2019/01
32.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/12
33.	Original article	Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to retuximab therapy between childhood-onset and adult-onset disease. 2018/10
34.	Original article	Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). 2018/10
35.	Original article	Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Repuired Surgical Treatment 2018/08
36.	Original article	A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement. 2018/05
37.	Original article	New Insights into Cystic Kidney Diseases. 2018/05
38.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/03
Display 5 items
Display all(38)

■ Academic conference presentation

1.	Sex Differences and Aging Influence the Association between Kidney Prognosis and Intracranial Aneurysms in Patients with ADPKD: Attribute-Based Medicine (ABM) Insights （Poster notice，General） 2024/10/26
2.	Hydroxychloroquine (HCQ)-Associated Zebra and Myeloid Bodies in Patients with Systemic Lupus Erythematosus (SLE) （Poster notice，General） 2024/10/25
3.	Relationship of tolvaptan dose with the rate of decline in kidney function in ADPKD patients. （Poster notice，Panelist at Symposium/Workshop (Applied)） 2019/11/07
4.	Elevation of the liver enzyme levels during tolvaptan treatment with autosomal dominant polycystic kidney disease (ADPKD) （Poster notice，General） 2018/02/22